VanEck Vectors Pharmaceutical ETF (PPH)

56.77
Delayed Data
As of Apr 20
 -0.31 / -0.54%
Today’s Change
53.38
Today|||52-Week Range
64.65
-4.28%
Year-to-Date

Investment Objective

The investment seeks to replicate as closely as possible- before fees and expenses- the price and yield performance of the MVIS- US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

No recent news for VanEck Vectors Pharmaceutical ETF.

Performance

1 month-0.56% 3 years-5.53%
3 months-8.73% 5 years+6.34%
1 year+7.58% Since inception+9.90%
Data through 04/21/2018

Quote Details

Previous close$57.08
Open day’s range56.67 – 57.11
Net asset value (NAV)56.79 (04/20/2018)
Daily volume9,192
Average volume (3 months)126,411
Data as of 3:59pm ET, 04/20/2018

Peer Comparisonvs. Health ETFs

 PPHCategory
Performance 5-yr return+6.34%+14.29%
Expense Gross exp ratio0.40%1.30%
Risk 5 year sharpe ratio0.530.92
Net assets$245.9M$3.0B
Average market cap$45.8B$10.0B
Average P/E15.522.2
Dividend / Share--0.30%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
GSK GlaxoSmithKline5.46%
AZN AstraZeneca5.39%
SNY Sanofi5.18%
MRK Merck5.12%
PFE Pfizer5.11%
NVS Novartis5.10%
JNJ Johnson & Johnson5.06%
NVO Novo Nordisk5.01%
BMY Bristol-Myers Squibb4.91%
JAZZ Jazz Pharmaceuticals PLC4.75%